The oncology clinical development playing field is competitive and always changing. Our oncology product platform enables you to set up a trial with a single, dedicated team. Our group has the therapeutic expertise and relationships with key opinion leaders in the field to advise you through the full product development spectrum — from early Phase I through global Phase III.

Whether you are developing specialized products or working through a complex trial, our team can help you through new, unusual and difficult designs.


In the last five years, Chiltern has conducted 518 oncology clinical trials.

Oncology Product Platform

Total Studies